Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pentraxin 3 Inhibits the Angiogenic Potential of Multiple Myeloma Cells.
Ronca R, Taranto S, Corsini M, Tobia C, Ravelli C, Rezzola S, Belleri M, De Cillis F, Cattaneo A, Presta M, Giacomini A. Ronca R, et al. Among authors: taranto s. Cancers (Basel). 2021 May 8;13(9):2255. doi: 10.3390/cancers13092255. Cancers (Basel). 2021. PMID: 34066669 Free PMC article.
Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression.
Matarazzo S, Melocchi L, Rezzola S, Grillo E, Maccarinelli F, Giacomini A, Turati M, Taranto S, Zammataro L, Cerasuolo M, Bugatti M, Vermi W, Presta M, Ronca R. Matarazzo S, et al. Among authors: taranto s. Cancers (Basel). 2019 Aug 30;11(9):1277. doi: 10.3390/cancers11091277. Cancers (Basel). 2019. PMID: 31480336 Free PMC article.
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress.
Ronca R, Ghedini GC, Maccarinelli F, Sacco A, Locatelli SL, Foglio E, Taranto S, Grillo E, Matarazzo S, Castelli R, Paganini G, Desantis V, Cattane N, Cattaneo A, Mor M, Carlo-Stella C, Belotti A, Roccaro AM, Presta M, Giacomini A. Ronca R, et al. Among authors: taranto s. Cancer Res. 2020 Jun 1;80(11):2340-2354. doi: 10.1158/0008-5472.CAN-19-2714. Epub 2020 Feb 24. Cancer Res. 2020. PMID: 32094301 Free article.
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
Chiodelli P, Coltrini D, Turati M, Cerasuolo M, Maccarinelli F, Rezzola S, Grillo E, Giacomini A, Taranto S, Mussi S, Ligresti A, Presta M, Ronca R. Chiodelli P, et al. Among authors: taranto s. Cancer Lett. 2022 Feb 1;526:217-224. doi: 10.1016/j.canlet.2021.11.030. Epub 2021 Dec 1. Cancer Lett. 2022. PMID: 34861311
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity.
Taranto S, Castelli R, Marseglia G, Scalvini L, Vacondio F, Gianoncelli A, Ribaudo G, Faletti J, Gazzaroli G, Rocca E, Ronca R, Rusnati M, Sacco A, Roccaro AM, Presta M, Mor M, Giacomini A, Rivara S. Taranto S, et al. Pharmacol Res. 2024 Aug;206:107291. doi: 10.1016/j.phrs.2024.107291. Epub 2024 Jul 3. Pharmacol Res. 2024. PMID: 38969274 Free article.
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.
Giacomini A, Taranto S, Gazzaroli G, Faletti J, Capoferri D, Marcheselli R, Sciumè M, Presta M, Sacco A, Roccaro AM. Giacomini A, et al. Among authors: taranto s. J Exp Clin Cancer Res. 2024 Nov 1;43(1):294. doi: 10.1186/s13046-024-03217-2. J Exp Clin Cancer Res. 2024. PMID: 39482742 Free PMC article. Review.
47 results